Clinical trial
Ticagrelor and Aspirin for the Prevention of Cardiovascular Events After Coronary Artery Bypass Surgery (CABG)
NCT01373411 is registered in ClinicalTrials.gov with Cardiology Research UBC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ticagrelor and Aspirin for the Prevention of Cardiovascular Events After Coronary Artery Bypass Surgery (CABG)
- Lead sponsor
- Cardiology Research UBC
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2011
- Completion date
- March 31, 2015
- Enrollment
- 70 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.